To this end, MTH1 inhibition can be superior to DNA repair targeting agents, since it is vital for the survival of tumor cells without affecting normal cells’ viability, a condition known as phenotypic lethality [34,35]. The gene discussed is NUDT1; the disease is neoplasm.